The dopamine D3 receptor and drug addiction: Studies with preclinical animal models

被引:0
|
作者
Gardner, E [1 ]
Ashby, CR [1 ]
Xi, ZX [1 ]
Pak, AC [1 ]
Gilbert, J [1 ]
Newman, AH [1 ]
Heidbreder, CA [1 ]
机构
[1] NIDA, Intramural Res Program, Baltimore, MD 21224 USA
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:S18 / S18
页数:1
相关论文
共 50 条
  • [1] The dopamine D3 receptor and drug addiction
    Pierre Sokoloff
    Bernard Le Foll
    Sylvie Perachon
    Regis Bordet
    Sophie Ridray
    Jean-Charles Schwartz
    Neurotoxicity Research, 2001, 3 : 433 - 441
  • [2] The dopamine D3 receptor and drug addiction
    Sokoloff, Pierre
    Le Foll, Bernard
    Perachon, Sylvie
    Bordet, Regis
    Ridray, Sophie
    Schwartz, Jean-Charles
    NEUROTOXICITY RESEARCH, 2001, 3 (05) : 433 - 441
  • [3] Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction
    Xi, Zheng-Xiong
    Gardner, Eliot L.
    CNS DRUG REVIEWS, 2007, 13 (02): : 240 - 259
  • [4] Drug design for addiction: Targeting the dopamine D3 receptor
    Newman, Amy
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [5] Dopamine D3 receptor agents as potential new medications for drug addiction
    Le Foll, B
    Schwartz, JC
    Sokoloff, P
    EUROPEAN PSYCHIATRY, 2000, 15 (02) : 140 - 146
  • [6] The relevance between dopamine D3 receptor gene variations and drug addiction
    Kalfoglu, Ersi Abaci
    Dashti, Reza
    Petridis, Gabriel
    Yukseloglu, E. Hulya
    Ozcan, S. Sebnem
    Beyazydrek, Mansur
    Atasoy, Sevil
    FORENSIC SCIENCE INTERNATIONAL GENETICS SUPPLEMENT SERIES, 2009, 2 (01) : 489 - 490
  • [8] Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings
    Le Foll, Bernard
    Collo, Ginetta
    Rabiner, Eugenii A.
    Boileau, Isabelle
    Pich, Emilio Merlo
    Sokoloff, Pierre
    DOPAMINE, 2014, 211 : 255 - 275
  • [9] Nicotine and dopamine D3 receptor: Implications in drug addiction and Parkinson's disease
    Le Foll, B
    Diaz, J
    Schwartz, JC
    Sokoloff, P
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S170 - S170
  • [10] Selective Antagonism at Dopamine D3 Receptors as a Target for Drug Addiction Pharmacotherapy: A Review of Preclinical Evidence
    Heidbreder, Christian
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2008, 7 (05) : 410 - 421